arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

C4 Therapeutics, Inc.

CCCC

$3.73 ▲ +0.08 (+2.33%) at close

29 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

C4 Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $470.3M

Dividend Yield —

Revenue Growth -15.0% ↘

Op. Margin -451.6% ↘

ROIC -9.4% ↘

FCF / Share $-0.24

Trailing P/E —

Price / Book 1.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

29-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$6.15M

↓ -15.0% —

Net Income Profit after all expenses

$-25.13M

↑ +4.5% —

Operating Margin Operating profit as % of sales

-451.6%

↓ -115.0% 0th

FCF / Share Free cash flow per share

$-0.24

↑ +49.3% —

Long-Term Debt Long-term obligations

$0.00

— —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-15.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-288%)	112.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1310%)	-26.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-436%)	-46.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-677%)	138.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1627%)	—	—	—	-19.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-339%)	—	—	—	—	-85.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1172%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	45.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	81.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-25.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-42.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	9.8% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	42.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	-9.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-145.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-27.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-9.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-32.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	97.1% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	94.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	94.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	-96.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	4.5% Caution ↓ Caution Declining Year-over-year change in net income	40.7% Excellent ↑ Excellent Improving Year-over-year change in net income	7.2% Fair → Fair Stable Year-over-year change in net income	7.2% Fair Fair Year-over-year change in net income	7.2% Fair Fair Year-over-year change in net income	—	—	—	18.5% Good Good Year-over-year change in net income	—	—	—	-10.0% Weak ↑ Weak Improving Year-over-year change in net income	-137.5% Weak ↓ Weak Declining Year-over-year change in net income	-50.8% Weak ↓ Weak Declining Year-over-year change in net income	-50.8% Weak ↓ Weak Declining Year-over-year change in net income	-50.8% Weak ↓ Weak Declining Year-over-year change in net income	28.2% Excellent ↑ Excellent Improving Year-over-year change in net income	4.0% Caution ↑ Caution Improving Year-over-year change in net income	-76.0% Weak ↑ Weak Improving Year-over-year change in net income	-76.0% Weak ↑ Weak Improving Year-over-year change in net income	-117.4% Weak Weak Year-over-year change in net income	-116.3% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	49.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	-25.6% Weak ↑ Weak Improving Year-over-year change in free cash flow	-137.9% Weak Weak Year-over-year change in free cash flow	-77.5% Weak Weak Year-over-year change in free cash flow	—	—	—	61.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	17.8% Excellent → Excellent Stable Compound annual revenue growth over 3 years	56.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	18.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-22.4% Weak Weak Compound annual revenue growth over 3 years	—	-36.4% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-451.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3111%)	-210.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1501%)	-306.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2143%)	-441.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3040%)	-402.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2786%)	—	-183.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1326%)	-178.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1291%)	—	—	—	—	—	—	-481.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3307%)	-197.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1420%)	—	-76.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-607%)	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	-0.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	0.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-6.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	-408.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3504%)	-186.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1650%)	-234.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2053%)	-407.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3494%)	-363.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3131%)	—	-184.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1638%)	-236.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2069%)	—	—	—	—	—	—	-468.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4001%)	-228.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2005%)	—	-78.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-750%)	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-487.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-201.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-281.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-189.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-459.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-346.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-157.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-41.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-463.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	178.7% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	-128.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.20x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.26x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.78x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.65x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.23x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	1.41x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-9.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-12.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	-10.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.5% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	7.9% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	9.8% Fair → Fair Stable Return earned on debt + equity capital invested Optimal: > 10%	9.3% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	10.4% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-8.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-8.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-9.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-4.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-10.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-8.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-17.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-214%)	-15.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-13.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-16.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-11.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-11.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	-11.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	—	—	—	-13.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-12.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-9.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-8.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-4.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-5.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-5.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-8.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-7.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	14.0% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-7%)	8.8% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-41%)	9.6% Caution → Caution Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-36%)	9.0% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-40%)	9.8% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-34%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	-0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-111%)	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	-84.25x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-90.96x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-86.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-73.02x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-66.32x Weak Weak Operating income divided by interest expense Optimal: > 5x	-64.10x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-57.29x Weak Weak Operating income divided by interest expense Optimal: > 5x	-52.65x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-61.27M	$-74.60M	$-58.81M	$-78.16M	$-51.29M	$-55.50M	$-59.65M	$-73.11M	$-89.66M	$-126.59M	$-60.97M	$-34.55M	$-37.73M	$-18.27M	$-38.25M	$-46.17M	$-35.06M	$-65.36M	$-152.16M	$-270.74M	$-84.68M	$-171.68M	$-53.56M	$-107.65M	$-73.86M	$-90.55M	$-100.97M	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	-0.33x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.30x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.35x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.41x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.35x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.72x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.44x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.48x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.51x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.54x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.54x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.05	—	$0.15	$0.09	$0.10	—	$0.22	$0.17	$0.04	—	—	—	$0.08	—	$0.14	$0.28	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.20	$-0.09	$-0.44	$-0.37	$-0.37	$-0.49	$-0.35	$-0.26	$-0.41	—	—	—	$-0.71	$-0.76	$-0.65	$-0.56	$-0.65	$-0.31	$-0.51	$-0.51	$-0.49	$30.93	$-17.55	$-9.28	$-9.59	$-8.44	$-8.93	—	—
Free Cash Flow per Share (USD)	$-0.24	—	$-0.44	$-0.17	$-0.47	—	$-0.35	$-0.07	$-0.26	—	—	—	$-0.69	—	$-0.64	$0.51	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$2.25	$2.65	$2.08	$2.45	$2.75	$3.06	$3.49	$3.59	$3.76	$4.07	$4.39	$4.76	$5.35	$5.91	$6.50	$7.05	$7.48	$8.00	$8.21	$8.61	$6.12	$6.52	$-95.42	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$2.25	$2.65	$2.08	$2.45	$2.75	$3.06	$3.49	$3.59	$3.76	$4.07	$4.39	$4.76	$5.35	$5.91	$6.50	$7.05	$7.48	$8.00	$8.21	$8.61	$6.12	$6.52	$-95.42	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	126.07M	—	72.56M	71.01M	70.83M	—	69.63M	68.81M	68.43M	—	—	—	49.03M	—	48.92M	48.82M	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$218.12M	$225.08M	$170.92M	$180.27M	$191.72M	$212.59M	—	—	$224.57M	$228.42M	$193.41M	$226.15M	$239.07M	$243.01M	$280.19M	$272.22M	$255.96M	$274.44M	$363.61M	$433.39M	$284.36M	$337.16M	$168.91M	—	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$10.34M	$11.75M	$11.48M	$11.30M	$11.12M	$10.94M	$10.77M	$10.59M	$10.41M	$10.23M	$10.05M	$9.88M	—	—	—	—	—	—
Total Equity (USD)	$234.25M	$256.59M	$154.41M	$174.06M	$195.14M	$215.99M	$242.66M	$247.06M	$258.28M	$246.11M	$216.02M	$233.71M	$262.47M	$289.23M	$318.18M	$344.59M	$364.53M	$389.61M	$398.78M	$416.43M	$263.70M	$280.79M	$-155.92M	$-135.06M	$-124.53M	$-111.96M	$-102.67M	$-93.41M	$-79.75M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$6.15M	$11.02M	$11.23M	$6.46M	$7.24M	$5.18M	$15.36M	$12.01M	$3.04M	—	—	—	$3.76M	$2.85M	$6.75M	$13.83M	—	$20.08M	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$404.00K	$377.00K	$460.00K	$615.00K	$456.00K	$364.00K	$442.00K	$448.00K	$448.00K	—	—	—	$545.00K	$521.00K	$415.00K	$435.00K	$305.00K	$323.00K	$330.00K	$388.00K	$451.00K	$365.00K	—	$416.00K	$416.00K	—	—	—	—
Net Income, GAAP (USD)	$-25.13M	$-20.49M	$-26.32M	$-26.32M	$-26.32M	$-34.57M	$-28.36M	$-28.36M	$-28.36M	—	—	—	$-34.78M	$-37.19M	$-31.62M	$-31.62M	$-31.62M	$-15.66M	$-20.97M	$-20.97M	$-20.97M	$-21.80M	$-21.84M	$-11.91M	$-11.91M	$-10.02M	$-10.09M	—	—
Operating Cash Flow (USD)	$-29.94M	$-22.14M	$-31.21M	$-12.06M	$-33.28M	$-17.93M	$-24.13M	$-4.97M	$-18.12M	—	—	—	$-33.12M	$-29.13M	$-28.02M	$28.02M	$-26.60M	$-25.67M	—	—	$-24.93M	$-21.59M	—	$-14.59M	$-16.67M	$-10.30M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 29 quarters

C4 Therapeutics, Inc.

Analytical Summary

29-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CCCC with peers